General Information of Disease (ID: DIS920N0)

Disease Name Bacterial endocarditis
Synonyms bacterial endocarditis; Bacteria endocarditis (disease); Bacteria caused endocarditis (disease); bacterial endocarditis (disease)
Definition Endocarditis that is caused by an infection with a bacterial agent.
Disease Hierarchy
DIS88NSA: Infective endocarditis
DIS5QJ9S: Bacterial infection
DISEM33Q: Infectious disease
DIS920N0: Bacterial endocarditis
Disease Identifiers
MONDO ID
MONDO_0006669
MESH ID
D004697
UMLS CUI
C0014121
MedGen ID
41779
HPO ID
HP:0006689
SNOMED CT ID
301183007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 2 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Ampicillin DMHWE7P Approved Small molecular drug [1]
Vancomycin DM3JFIH Approved NA [2]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Benzylpenicillin DMS9503 Phase 3 Small molecular drug [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
AQP9 TTQEI32 Strong Biomarker [4]
MTM1 TTY2TCU Strong Biomarker [5]
------------------------------------------------------------------------------------
This Disease Is Related to 8 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CNMD OTHND8EL moderate Biomarker [6]
ARSD OTAHW9M8 Strong Biomarker [7]
CYP4V2 OTQKNK0D Strong Biomarker [8]
ITGA2B OT4Y17PY Strong Biomarker [9]
MANEA OTV7L8I6 Strong Biomarker [10]
MCF2L2 OTOGFMIH Strong Biomarker [11]
NLRP6 OTEREN4W Strong Biomarker [12]
MAVS OTTQ0J64 Definitive Biomarker [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DOT(s)

References

1 Ampicillin FDA Label
2 Vancomycin FDA Label
3 Optimisation of the prevention and treatment of bacterial endocarditis. Drugs Aging. 2001;18(6):415-24.
4 The gene expression analysis of blood reveals S100A11 and AQP9 as potential biomarkers of infective endocarditis.PLoS One. 2012;7(2):e31490. doi: 10.1371/journal.pone.0031490. Epub 2012 Feb 3.
5 Multilocus sequence typing analysis of Streptococcus mutans strains with the cnm gene encoding collagen-binding adhesin.J Med Microbiol. 2011 Nov;60(Pt 11):1677-1684. doi: 10.1099/jmm.0.033415-0. Epub 2011 Jun 16.
6 Chondromodulin-1 in health, osteoarthritis, cancer, and heart disease.Cell Mol Life Sci. 2019 Nov;76(22):4493-4502. doi: 10.1007/s00018-019-03225-y. Epub 2019 Jul 17.
7 Infective endocarditis after device closure of atrial septal defects: Case report and review of the literature.Catheter Cardiovasc Interv. 2017 Feb 1;89(2):324-334. doi: 10.1002/ccd.26784. Epub 2016 Sep 19.
8 Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.Infect Immun. 2013 Mar;81(3):697-703. doi: 10.1128/IAI.01030-12. Epub 2012 Dec 17.
9 Multiple sites on Streptococcus gordonii surface protein PadA bind to platelet GPIIbIIIa.Thromb Haemost. 2013 Dec;110(6):1278-1287. doi: 10.1160/TH13-07-0580. Epub 2013 Oct 17.
10 Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.Eur Heart J. 2019 Oct 14;40(39):3222-3232. doi: 10.1093/eurheartj/ehz620.
11 Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact.Clin Cardiol. 2019 Apr;42(4):432-437. doi: 10.1002/clc.23162. Epub 2019 Mar 14.
12 Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement.Eur Heart J. 2018 Jul 21;39(28):2668-2675. doi: 10.1093/eurheartj/ehy153.
13 Heterogeneous vancomycin-intermediate susceptibility in a community-associated methicillin-resistant Staphylococcus aureus epidemic clone, in a case of Infective Endocarditis in Argentina.Ann Clin Microbiol Antimicrob. 2011 Apr 28;10:15. doi: 10.1186/1476-0711-10-15.